Klaria Pharma Holding AB (STU:6FN) Valuation Rank

View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Klaria Pharma Holding AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Klaria Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Valuation Rank

Traded in Other Exchanges

KLAR:Sweden

Address

Virdings Alle 2, Uppsala, SWE, 754 50

Website

https://www.klaria.com

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.